https://www.theedgeresearch.com/news TheEdgeResearch en 2026-10-25 Tech stocks are being repriced, not headed for a dot-com-style crash: Strategist 2026-10-25 https://www.theedgeresearch.com/quote/UBS TheEdgeResearch en 2026-10-25 Employees group warns of major Swiss job losses if UBS relocates, newspaper says 2026-10-25 https://www.theedgeresearch.com/quote/MSFT TheEdgeResearch en 2026-10-25 Here's the Price at Which I'd Buy Microsoft Stock 2026-10-25 https://www.theedgeresearch.com/quote/4929.T TheEdgeResearch en 2026-10-25 Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) 2026-10-25 https://www.theedgeresearch.com/quote/COLB TheEdgeResearch en 2026-10-25 Columbia Banking System: Massive Share Repurchase And A 5% Yield 2026-10-25 https://www.theedgeresearch.com/quote/SPCX TheEdgeResearch en 2026-10-25 Elon Musk Wants to Give Every American Child a Share of SpaceX. Here's What It Would Cost -- and What It Means for Everyone Else Holding the Stock 2026-10-25 https://www.theedgeresearch.com/quote/XNCR TheEdgeResearch en 2026-10-25 Xencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell Renal Cell Carcinoma and ENPP3+ Tumors 2026-10-25 https://www.theedgeresearch.com/quote/OCUL TheEdgeResearch en 2026-10-25 Ocular Therapeutix: The Drug Won, The Stock Lost, And That's The Opportunity 2026-10-25 https://www.theedgeresearch.com/quote/MU TheEdgeResearch en 2026-10-25 Nvidia vs. Micron: The AI Revolution Is Big Enough for Both. Here's the Better Buy. 2026-10-25 https://www.theedgeresearch.com/quote/AMGN TheEdgeResearch en 2026-10-25 Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Better Buy? 2026-10-25